Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
EP Biocomposites Ltd (543595)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543595 NSE: Plastic Products | Small Cap | EP Biocomposites Share Price
₹100 0.00 (0.00%)
As on 18-Sep'26 16:59
EP Biocomposites Ltd (543595)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543595 NSE: Plastic Products | Small Cap | EP Biocomposites Share Price
₹100 0.00 (0.00%)
As on 18-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹17 Cr.
Current Price
₹100
52-Week Low / High
₹76 / 150
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
36.7
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
4.98%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
70.08%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹1.7 Cr.
Face Value
₹10
All Time Low / High
₹75.50 / 364.25
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is EP Biocomposites Ltd a good quality company?
EP Biocomposites Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does EP Biocomposites Ltd performance compare with that of its Peers?
Revenue growth of EP Biocomposites Ltd vs industry peers?
EP Biocomposites Ltd revenue CAGR is %, compared to the industry median CAGR of 0.07%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of EP Biocomposites Ltd?
Promoters hold 70.08% of the EP Biocomposites Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of EP Biocomposites Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -23.34% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
EP Biocomposites Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 140% | 223% | 41.8% | 13.2% | 15.3% | 14.2% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | 9.0 | 14.9 | 2.0 | -0.1 | 0.1 | 0.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0.6 | 3 | 8.1 | 7.1 | 11.4 | 12 | 14 |
| Sales YoY Gr. | - | NA | NA | NA | NA | 417.5% | 173.2% | -11.5% | 60.5% | 5% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | 0 | 0.8 | 9.6 | 6.9 | 3.4 | 6.8 | 6.1 | 8.7 |
| YoY Gr. | - | NA | NA | NA | NA | 1036.9% | -28.1% | -50.1% | 99.4% | -10.4% | - |
| BVPS (₹) ⓘ | 0 | 0 | 0 | 0 | 0.8 | 10.3 | 17 | 50 | 56.9 | 63 | 63 |
| Adj Net Profit ⓘ | 0 | 0 | 0 | 0 | 0 | 0.4 | 0.8 | 0.6 | 1.2 | 1 | 1 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0 | 0 | 0.1 | 0 | -4.3 | -0.8 | -1.2 | -0.5 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1.6 | -1.5 | -6.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 84% | 14.2% | 5% | ||||
| Adj EPS ⓘ | NA | 48.8% | -3.7% | -10.4% | ||||
| BVPSⓘ | NA | 142% | 54.9% | 10.8% | ||||
| Share Price | - | - | -23.3% | -16.6% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 110.5 | 172.5 | 67.9 | 11.1 | 12.8 | 10.2 | 13.8 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 7.6 | 15.7 | 17.5 | 13.7 | 12.3 | 14.8 | NAN |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 5.5 | 12.1 | 10 | 8.1 | 10.1 | 8.6 | 10.7 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0.1 | 0 | 2.1 | 0.2 | 0.2 | 0.3 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 100 | 224 | 458 | 359 | 425 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 16 | 136 | 278 | 190 | 247 | 0 |
Valuation of EP Biocomposites - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
EP Biocomposites Ltd FAQs
The current trading price of EP Biocomposites on 18-Sep-2026 16:59 is ₹100.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Sep-2026 the market cap of EP Biocomposites stood at ₹16.82 Cr
The latest P/E ratio of EP Biocomposites as of 17-Sep-2026 is 11.52.
The latest P/B ratio of EP Biocomposites as of 17-Sep-2026 is 1.59.
The 52-week high of EP Biocomposites is ₹149.9 and the 52-week low is ₹75.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EP Biocomposites is ₹13.64 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that EP Biocomposites Ltd is a below average quality company.
The key valuation ratios of EP Biocomposites Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of EP Biocomposites Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About EP Biocomposites Ltd
The company was incorporated as ‘EP Biocomposites Limited’ on January 17, 2020 under the Companies Act, 2013 with the Registrar of Companies, Goa Registration No.014240. A certificate of incorporation was issued on January 17, 2020 by the Registrar of Companies, Goa.
The company was incorporated on January 17, 2020 and is into manufacturing and supply of fibre re-inforced polymers (FRP) products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications which meets customer requirements. The company got into highly potential sector of waste water recycling in 2021. The company has taken over the running business of it promoter, Om Ventures, a sole proprietorship through a business transfer agreement dated August 31, 2021.
The company focuses on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. It provides sanitation infrastructure and human waste management solutions and services, involving innovative and simple bio-digester technology licensed from Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India. The anaerobic bio-digester technology helps users manage waste onsite, without depending on expensive and energy-consuming sewage infrastructure.
Business area of the company
EP Biocomposites is the manufacturer and supplier of fibre reinforced polymers (FRP) products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications which meets customer requirements.
Key Events
- January, 2020: Incorporation of Company.
- August, 2021: Takeover of Proprietorship Concern pursuant to Business Takeover Agreement dated August 31, 2021.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
